Case series:apatinib combined with chemotherapy

2 trials

Sponsors

Zhejiang Cancer Hospital, The Second Affiliated Hospital of Chongqing Medical University

Conditions

Ovarian cancersensitive/platinum-resistant recurrent ovarian cancer

Phase 4

Study of apatinib combined with chemotherapy in the platinum resistant / refractory recurrent epithelial ovarian cancer, tubal cancer or peritoneal cancer

RecruitingChiCTR1800016847

Zhejiang Cancer HospitalOvarian cancer

Start: 2018-07-01Updated: 2018-07-02

Clinical efficacy and safety of apatinib combined with chemotherapy in the treatment of platinum-sensitive/platinum-resistant recurrent ovarian cancer

RecruitingChiCTR1800019210

The Second Affiliated Hospital of Chongqing Medical Universitysensitive/platinum-resistant recurrent ovarian cancer

Start: 2018-11-01Updated: 2018-11-05